Landlocked developing countries (LLDCs) vs Luxembourg: Proportion of the target population who received a 3rd dose of
Landlocked developing countries (LLDCs)
76.0%
in 2024
Luxembourg
97.0%
in 2024
Landlocked developing countries (LLDCs) rank
8th
Luxembourg rank
11th
Proportion of the target population who received a 3rd dose of over time
- Landlocked developing countries (LLDCs)
- Luxembourg
How they compare
Luxembourg currently reports 97.0% against 76.0% in Landlocked developing countries (LLDCs), a difference of 21.0%.
That makes Luxembourg's figure about 1.3 times Landlocked developing countries (LLDCs)'s.
Across all 15 years both countries report, Luxembourg has been ahead every year.
Landlocked developing countries (LLDCs) ranks 8th and Luxembourg ranks 11th of 19 regions.
Luxembourg has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 44.0% | 93.4% | 49.4% | Luxembourg |
| 2020s | 72.2% | 96.6% | 24.4% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Landlocked developing countries (LLDCs) or Luxembourg?
- Luxembourg, at 97.0% against 76.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Landlocked developing countries (LLDCs) and Luxembourg?
- 21.0%, with Luxembourg ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Luxembourg?
- 15 years are reported by both, from 2010 to 2024.
- How do Landlocked developing countries (LLDCs) and Luxembourg rank globally for proportion of the target population who received a 3rd dose of?
- Landlocked developing countries (LLDCs) ranks 8th and Luxembourg ranks 11th of 19 regions.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.